maleic-acid and calcium-aluminate

To improve the bioactivity of calcium aluminate cement (CAC), which has the potential of restoring defective bone and the joints between artificial prostheses and natural bone, lithium fluoride and maleic acid were added to CAC. Then the bioactivity of the CAC, together with the lithium fluoride and maleic acid, was estimated by examining the hydroxyapatite (HAp) formation on its surface in simulated body fluid (SBF). When 0.5 g of lithium fluoride and 8.75 g of maleic acid were added to 100 g of CAC, LiAl(2)(OH)(7).2H(2)O was formed on the surface of CAC after 1 day of soaking, and HAp was formed after 2 days. The depth of the LiAl(2)(OH)(7). 2H(2)O and HAp-mixed layers after 60 days of immersion was approximately 20 microm. However, after CAC, which contains only 8.75 g of maleic acid per 100 g of CaO.Al(2)O(3), had been soaking for just 30 days, 3CaO.Al(2)O(3).6H(2)O and HAp were detected. These results indicate that lithium fluoride accelerates HAp formation on the surface of CAC in SBF while maleic acid has little influence on HAp formation. The promotion of HAp formation on the surface of CAC in SBF can be explained in terms of the help of an intermediate layer, LiAl(2)(OH)(7).2H(2)O, which contains hydroxyl groups that act as the nuclei of HAp formation and a tremendous dissolution of calcium ions from CAC into the SBF solution within a short induction time.

Topics: Aluminum Compounds; Biocompatible Materials; Body Fluids; Calcium Compounds; Durapatite; Fluorides; Lithium Compounds; Maleates; Microscopy, Electron, Scanning

We investigated lithium fluoride (LiF) and maleic acid (MA) containing calcium aluminate cement (CAC) for hard tissue repair. The objective of this study is to estimate the addition effects of LiF and MA on setting behavior, compressive strength, and biocompatibility of CAC and to find the most compatible composition of LiF and MA for using CAC as a new bone cement. The CAC was composed mainly of CaO. Al(2)O(3). Samples of LiF and MA containing CAC were formed along with recording of setting time and peak temperature and then set cement was analyzed by X-ray diffraction (XRD). Agar diffusion test, tetrazolium bromide (MTT) assay, and hemolysis test were used to detect initial in vitro biocompatibility of LiF and MA containing CAC. It was revealed from the results that LiF shortened setting time and decreased compressive strength, whereas MA delayed setting time and increased compressive strength. However, LiF and MA showed no or little influence on maximum temperature of CAC. CAC containing 0.5 g of LiF and 8.75 g of MA showed the highest compressive strength (111.64 +/- 7.74 MPa) across all the experimental compositions. The CACs containing 0.5 g of LiF/8.75 g of MA and 1.01 g LiF/8.75 g of MA had no cytotoxicity and hemolysis. In this study, CAC with 0.5 g of LiF and 8.75g of MA showed the most compatible properties for using bone cement, and thus it was assessed a candidate for a new bone cement along with CAC.

Topics: Aluminum Compounds; Animals; Biocompatible Materials; Bone Cements; Calcium Compounds; Cell Line; Compressive Strength; Fibroblasts; Fluorides; Lithium Compounds; Male; Maleates; Materials Testing; Mice; Temperature; Time Factors; X-Ray Diffraction